Current:Home > ScamsThe FDA warns consumers to stop using several eyedrop products due to infection risk-Angel Dreamer Wealth Society D1 Reviews & Insights
The FDA warns consumers to stop using several eyedrop products due to infection risk
View Date:2024-12-23 14:28:22
U.S. health officials are warning consumers to stop using more than two dozen over-the-counter eye drop products due to the potential risk of eye infection that could lead to vision loss.
The Food and Drug Administration on Friday issued the alert for 26 products from the following brands: CVS Health, Leader (Cardinal Health), Rugby (Cardinal Health), Rite Aid, Target Up&Up and Velocity Pharma.
The federal regulatory agency said it recommended the manufacturers to recall of the subject products on Wednesday, after FDA investigators found bacterial contamination in critical drug production areas of a manufacturing facility.
CVS, Rite Aid and Target are removing the products in store and online, according to the FDA. Products branded as Leader, Rugby and Velocity may still be available but should not be purchased, said the agency. None of the products have caused adverse effects in consumers yet, they added.
It's the FDA's latest statements in a series of warnings against using eyedrop products linked to potential contamination. Two months ago, the FDA urged consumers to stop using two eyedrop products due to bacterial and fungal contamination. At the time, the drug-resistant bacteria Pseudomanas aeruginosa, Mycobacterium, Mycolicibacterium and Methylorubrum was found in LightEyez MSM Eye Drops Eye Repair product; Dr. Berne's MSM Drops 5% Solution was contaminated with Exophiala fungi.
In February, the Centers for Disease Control and Prevention reported an outbreak of Pseudomonas aeruginosa tied to the contamination of other brands of artificial tears and eyedrops.
As NPR previously reported, the bacteria strain was found in 81 people, four of whom had died from infections, the CDC said in May.
Over 10 different brands were linked to the infections, the most common being Ezri Care Artificial Tears from India-based Global Pharma Healthcare. The FDA said Global Pharma's microbial testing of its eye product was inadequate and that the pharmaceutical provider failed to use adequate, tamper-resistant packaging and distributed the drugs without proper preservatives.
Two additional companies recalled eyedrop products in February, although those products were not linked to the infections at the time.
In its Friday notice, the FDA did not specify the bacteria strain that was found at the manufacturing site.
veryGood! (77)
Related
- In bizarro world, Tennessee plays better defense, and Georgia's Kirby Smart comes unglued
- Maui residents wonder if their burned town can be made safe. The answer? No one knows
- A very Planet Money Thanksgiving
- Missouri governor granting pardons at pace not seen since WWII era
- Early Black Friday Deals: 70% Off Apple, Dyson, Tarte, Barefoot Dreams, Le Creuset & More + Free Shipping
- West Africa responds to huge diphtheria outbreaks by targeting unvaccinated populations
- FBI ends investigation of car wreck at Niagara Falls bridge, no indication of terrorism
- All the Reasons to Be Thankful for Ina Garten and Husband Jeffrey's Delicious Love Story
- Justice Department says jail conditions in Georgia’s Fulton County violate detainee rights
- Israel and Hamas have reached a deal on a cease-fire and hostages. What does it look like?
Ranking
- Brianna LaPaglia Addresses Zach Bryan's Deafening Silence After Emotional Abuse Allegations
- Stellantis recalls more than 32,000 hybrid Jeep Wrangler SUVs because of potential fire risk
- Nevada judge rejects attempt to get abortion protections on 2024 ballot
- Hope for Israel-Hamas cease-fire, but no relief yet for Gaza's displaced, or for Israeli hostages' families
- 'Joker 2' actor pans DC sequel as the 'worst film' ever: 'It has no plot'
- What the events leading up to Sam Altman’s reinstatement at OpenAI mean for the industry’s future
- Jamie Foxx accused of 2015 sexual assault at a rooftop bar in new lawsuit
- Israel-Hamas truce deal for hostage release hits last-minute snag, now expected to start Friday
Recommendation
-
Republican Vos reelected as Wisconsin Assembly speaker despite losing seats, fights with Trump
-
Sam Altman to join Microsoft research team after OpenAI ousts him. Here's what we know.
-
What's so great about Buc-ee's? Fans love the food, gas pumps, mascot, sparkling bathrooms
-
A crane operator has rescued a man from a burning high-rise in England
-
Beyoncé nominated for album of the year at Grammys — again. Will she finally win?
-
FBI ends investigation of car wreck at Niagara Falls bridge, no indication of terrorism
-
Balloons, bands, celebrities and Santa: Macy’s Thanksgiving Day Parade kicks off
-
Hezbollah fires rockets at north Israel after an airstrike kills 5 of the group’s senior fighters